G. Moro et al., DOES CONCOMITANT CHEMORADIOTHERAPY INFLUENCE COSMETIC OUTCOME IN CONSERVATIVE TREATMENT OF BREAST-CANCER, Tumori, 83(4), 1997, pp. 743-747
Purpose: To evaluate retrospectively factors influencing the cosmetic
outcome after conservative treatment for breast cancer. Material and m
ethods: From 1988 until 1992, 164 patients were treated with conservat
ive surgery (quadrantectomy) and radiotherapy with Co-60 (50 Gy On the
whole breast) plus 10 Gy on the surgical bed (300 kV photons) for T1-
T2 breast cancers; 46 patients (28%) received concomitant adjuvant che
motherapy (CMF schedule). Cosmesis evaluation was carried out after 24
to 108 months (median, 38 months). A logistic regression analysis was
performed to identify independent variables influencing the aesthetic
outcome. P values of 0.05 or less were considered significant. Result
s: Univariate analysis showed that T2 versus T1 (P = 0.0102), lower qu
adrants site (P = 0.0002) and concomitant adjuvant chemotherapy (P = 0
.0009) produced a worse aesthetic outcome. Multivariate analysis confi
rmed the same factors: tumor size (P = 0.0020), tumor site (P = 0.0150
) and concomitant chemotherapy (P = 0.0024). Conclusions: The signific
ant negative influence on the cosmetic outcome of concomitant adjuvant
chemotherapy implies questions about the timing of radiotherapy and c
hemotherapy in breast cancer conservative treatment.